Abstract
Introduction
Dermatomyositis (DM) is a rare autoimmune myopathy characterized by skin lesions, proximal muscle weakness and muscle inflammation. The pathogenesis of DM is unclear, and identification of reliable biomarkers for early diagnosis of DM is critical for design of a specific therapy for this disease.
Objectives
To find and identify potential serum biomarkers in DM patients.
Methods
We performed an untargeted metabolomic approach using UHPLC-MS/MS. The blood serum metabolomic profiles of 26 DM patients and 26 healthy controls were collected. Multivariate analysis of the metabolomic profile was applied to differentiate DM patients and controls and to find potential biomarkers.
Results
A significantly disturbed metabolic profile of DM patients was observed. Pathway analysis showed that aminoacyl-tRNA biosynthesis, phenylalanine, tyrosine and tryptophan biosynthesis, and nitrogen metabolism are the most prominently altered pathways in DM. Receiver operating characteristic curve indicated that glutamine, methionine, isoleucine, tryptophan, glutamic acid, indole, protocatechuic acid, and phenylalanine were potential biomarkers for DM diagnosis in terms of both sensitivity and specificity.
Conclusions
Our study provides new insight into underlying mechanisms of DM, and we suggest that we should pay more attention to these metabolic pathways in the prevention and treatment of DM.
Similar content being viewed by others
References
Bendewald, M. J., Wetter, D. A., Li, X., et al. (2010). Incidence of dermatomyositis and clinically amyopathic dermatomyositis: A population-based study in Olmsted County, Minnesota. Archives of Dermatology, 146, 26–30.
Bernatsky, S., Joseph, L., Pineau, C. A., et al. (2009). Estimating the prevalence of polymyositis and dermatomyositis from administrative data: Age, sex and regional differences. Annals of the Rheumatic Diseases, 68, 1192–1196.
Bohan, A., & Peter, J. B. (1975a). Polymyositis and dermatomyositis (first of two parts). New England Journal of Medicine, 292, 344–347.
Bohan, A., & Peter, J. B. (1975b). Polymyositis and dermatomyositis (second of two parts). New England Journal of Medicine, 292, 403–407.
Cooper, G. S., & Stroehla, B. C. (2003). The epidemiology of autoimmune diseases. Autoimmunity Reviews, 2, 119–125.
Dalakas, M. C. (1991). Polymyositis, dermatomyositis and inclusion-body myositis. New England Journal of Medicine, 325, 1487–1498.
Dalakas, M. C., & Hohlfeld, R. (2003). Polymyositis and dermatomyositis. Lancet, 362, 971–982.
Eisenberg, D., Almassy, R. J., Janson, C. A., et al. (1987). Some evolutionary relationships of the primary biological catalysts glutamine synthetase and RuBisCO. Cold Spring Harbor Symposia on Quantitative Biology, 52, 483–490.
Gostner, J. M., Becker, K., Kofler, H., et al. (2016). Tryptophan metabolism in allergic disorders. International Archives of Allergy and Immunology, 169, 203–215.
Lai, H. S., Lee, J. C., Lee, P. H., et al. (2005). Plasma free amino acid profile in cancer patients. Seminars in Cancer Biology, 15, 267–276.
Liaw, S. H., Pan, C., & Eisenberg, D. (1993). Feedback inhibition of fully unadenylylated glutamine synthetase from Salmonella typhimurium by glycine, alanine, and serine. Proc Natl Acad Sci USA, 90, 4996–5000.
Lichter-Konecki, U., Hipke, C., & Konecki, D. (1999). Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Molecular Genetics and Metabolism, 316, 308–316.
Liesenfeld, D. B., Habermann, N., Owen, R. W., et al. (2013). Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiology, Biomarkers and Prevention, 22, 2182–2201.
Mainetti, C., Terziroli Beretta-Piccoli, B., & Selmi, C. (2017). Cutaneous manifestations of dermatomyositis: A comprehensive review. Clinical Reviews in Allergy and Immunology, 53, 337–356.
Neurauter, G., Grahmann, A. V., Klieber, M., et al. (2008). Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Letters, 272, 141–147.
Olazagasti, J. M., Baez, P. J., Wetter, D. A., et al. (2015). Cancer risk in dermatomyositis: A meta-analysis of cohort studies. American Journal of Clinical Dermatology, 16, 89–98.
Palego, L., Betti, L., Rossi, A., et al. (2016). Tryptophan biochemistry: Structural, nutritional, metabolic, and medical aspects in humans. Journal of Amino Acids, 2016, 8952520.
Palmieri, E. M., Spera, I., Menga, A., et al. (2014). Glutamine synthetase desensitizes differentiated adipocytes to proinflammatory stimuli by raising intracellular glutamine levels. FEBS Letters, 588, 4807–4814.
Plotz, P. H., Dalakas, M., Leff, R. L., et al. (1989). Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders. Annals of Internal Medicine, 111, 143–157.
Rabinowitz, J. D., Purdy, J. G., Vastag, L., et al. (2011). Metabolomics in drug target discovery. Cold Spring Harbor Symposia on Quantitative Biology, 76, 235–246.
Schnackenberg, L. K. (2007). Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Review of Molecular Diagnostics, 7, 247–259.
Tolstikov, V. (2016). Metabolomics: Bridging the gap between pharmaceutical development and population health. Metabolites, 6, E20.
Tsugawa, H., Cajka, T., Kind, T., et al. (2015). MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nature Methods, 12, 523–526.
Xia, J., Psychogios, N., Young, N., et al. (2009). MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Research, 37, W652–660.
Acknowledgements
We thank all participants in this study and the clinical doctors from the China-Japan Friendship Hospital for collection of samples. This work was supported by the National Natural Science Foundation of China (Grants 81301801 and 81430056), Science and Technology Planning Project of Chaoyang District, Beijing (CYSF1835), R&D Infrastructure and Facility Development Program of Fujian (2018H2002), Industry University Research Project of Fujian (2018H6101), and the National Health and Family Planning Commission of the People’s Republic of China (Grant W2015CAE016).
Author information
Authors and Affiliations
Contributions
TZ and JX provided and pretreated the samples; JL performed the LC-MS analysis; JL and YL performed the data analysis and co-wrote the paper. All authors read and approved the manuscript.
Corresponding authors
Ethics declarations
Conflicts of interest
The authors declare no conflict of interest.
Ethical approval
This study was approved by the Ethics Committee of the China-Japan Friendship Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhang, T., Xu, J., Liu, Y. et al. Metabolomic profiling for identification of potential biomarkers in patients with dermatomyositis. Metabolomics 15, 77 (2019). https://doi.org/10.1007/s11306-019-1539-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-019-1539-9